Deliargyris Efthymios (CIK 0001751617)

Latest company ownership

Role: Chief Medical Officer
Shares held
95,000
Last filed at
Aug 8, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 13, 2023 Dec 15, 2023 Cytosorbents Corp Chief Medical Officer Buy 86.3 +22,557 6.92% $30K